CareRx Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA14173C1059
CAD
3.88
0.86 (28.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

17.95 k

Shareholding (Dec 2016)

FII

0.06%

Held by 1 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Healthy long term growth as Net Sales has grown by an annual rate of 22.29%

 
2

With a growth in Net Profit of 147.14%, the company declared Outstanding results in Jun 25

3

Risky -

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 244 Million (Small Cap)

stock-summary
P/E

224.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.36

stock-summary
Return on Equity

1.76%

stock-summary
Price to Book

2.80

Revenue and Profits:
Net Sales:
91 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.8%
0%
11.8%
6 Months
3215.11%
0%
3215.11%
1 Year
3361.2%
0%
3361.2%
2 Years
1821.74%
0%
1821.74%
3 Years
554.85%
0%
554.85%
4 Years
1120.13%
0%
1120.13%
5 Years
1520.04%
0%
1520.04%

CareRx Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
19.87%
EBIT Growth (5y)
61.23%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.52
Tax Ratio
0.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
4.21%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
224
Industry P/E
Price to Book Value
2.58
EV to EBIT
30.72
EV to EBITDA
9.56
EV to Capital Employed
2.11
EV to Sales
0.72
PEG Ratio
2.13
Dividend Yield
NA
ROCE (Latest)
6.86%
ROE (Latest)
0.29%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2016stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.01% vs -2.82% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 200.00% vs 109.09% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.40",
          "val2": "89.60",
          "chgp": "2.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.50",
          "val2": "7.40",
          "chgp": "1.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "1.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.60",
          "val2": "0.20",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.00%",
          "val2": "29.00%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.08% vs -2.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.67% vs 84.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "366.70",
          "val2": "370.70",
          "chgp": "-1.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.60",
          "val2": "27.20",
          "chgp": "-2.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "15.60",
          "chgp": "-41.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.10",
          "val2": "-2.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.50",
          "val2": "-5.40",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.30%",
          "val2": "19.50%",
          "chgp": "0.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary

Jun'25
Mar'25
Change(%)
Net Sales
91.40
89.60
2.01%
Operating Profit (PBDIT) excl Other Income
7.50
7.40
1.35%
Interest
1.80
1.80
Exceptional Items
-0.40
-0.50
20.00%
Consolidate Net Profit
0.60
0.20
200.00%
Operating Profit Margin (Excl OI)
32.00%
29.00%
0.30%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.01% vs -2.82% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 109.09% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
366.70
370.70
-1.08%
Operating Profit (PBDIT) excl Other Income
26.60
27.20
-2.21%
Interest
9.20
15.60
-41.03%
Exceptional Items
-2.10
-2.10
Consolidate Net Profit
-4.50
-5.40
16.67%
Operating Profit Margin (Excl OI)
20.30%
19.50%
0.08%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.08% vs -2.88% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.67% vs 84.30% in Dec 2023

stock-summaryCompany CV
About CareRx Corp. stock-summary
stock-summary
CareRx Corp.
Pharmaceuticals & Biotechnology
CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Company Coordinates stock-summary
Company Details
20 Eglinton Ave W , TORONTO ON : M4R 1K8
Registrar Details